Hypothesis testing using a frequentist approach is the mainstay of biostatistics and forms the foundation for assessing the significance of study results. This classical method has well-understood advantages as it determines whether data are statistically improbable and provides a threshold (ie, the P value) for delineating significance. Alternative statistical approaches have been proposed, including Bayesian analysis. This technique incorporates a prior probability as to what is already known clinically with the observed data. It is important for otolaryngologists to understand the advantages and disadvantages of these 2 approaches to conduct the most appropriate analyses.
As physicians, we expect the practice of otolaryngology to evolve over time. New operative techniques emerge and are vetted; novel medicines and perioperative regimens are investigated in clinical trials. If these interventions prove safe and effective, they may then be incorporated into routine patient care. Despite medical advancements, some elements of daily practice remain necessary cornerstones, such as obtaining a history and performing a physical examination. Thus, our evolving expertise combines both the old and the new.
Similarly, the field of statistics relies on tried and true approaches but also seeks to understand new reliable techniques. Null hypothesis significance testing using a frequentist approach has been the workhorse of biostatistics, forming the basis for assessing significance in most clinical studies. Hypothesis testing has well-understood advantages: it analyzes data to determine whether results are statistically improbable and provides a threshold for delineating significance (ie, the ubiquitous P \ .05). The P value reflects the probability of the results being equal to or more extreme than the observed value and is a widely used and accepted metric. 1 Hypothesis testing also has disadvantages. While the P value reflects the compatibility of data with a proposed model that exists if a given null hypothesis is true, it does not translate into a determination of whether the studied hypothesis is actually correct.
1-3 It also does not reflect the magnitude of any existing effect, and miniscule P values can occur in the context of negligible clinical impact. In addition, the threshold value has been arguably defined in an arbitrary way. Although a P value of .051 is similar to a P value of .049, they have typically been interpreted as starkly different results. However, had fate defined that ''bright line'' of significance as a P value of .01 instead, then both of the above values could have been interpreted as nonsignificant. 2 Due to the disadvantages and common misinterpretations of the frequentist approach, alternative techniques have been proposed. One approach defines not only the point estimate in the results but also a measure of what the results are expected to be in 95% of replications of the study. 3 This method recapitulates the familiar 95% confidence interval, which is a general requirement in data reporting for some journals. 4, 5 Another alternative approach is to use Bayesian analysis, which is well described in the commentary by Buchinksy and Chada, ''To P or Not to P.'' 6 The Bayesian technique incorporates a prior probability based on previous information and is predicated on the need to place new data in the context of what is already known, as well as the inevitable scrutiny of clinician judgment. 7 The underlying concept is familiar to many physicians, as it is an accepted approach when assessing diagnostic tests. 8, 9 It is the basis of the landmark Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) study 10 and necessary to understand the probabilities associated with clinical tests such as fine-needle aspiration. 11, 12 Instead of generating a P value that reflects the probability of the results given that the null hypothesis is true, Bayesian analysis calculates posterior probabilities and generates a posterior predictive probability (PPP). This PPP reflects the proportion of x 2 values obtained in model simulations that exceed the measured data, and a PPP near 0.5 indicates that the Bayesian model fits the observed results well. 13 Bayesian analysis has multiple advantages. First, it accepts the inevitability of uncertainty. Whereas more traditional frequentist approaches expect there to be one true population value, the Bayesian approach expects that there will be a range of values that reflects the uncertainty inherent to multiple unknown parameters. 7 Second, it calculates a posterior probability interval (PPI), also known as a credible interval. This PPI/credible interval reflects a 95% probability that the population parameter lies within its defined range. Third, it places the currently observed results in the context of previously published data and interprets extreme results with a more circumspect eye. Finally, the approach allows for subanalyses without the need for the classic statistical adjustments for multiple comparisons and may remain apt with smaller sample sizes. 7 Bayesian analysis combines clinical or scientific knowledge with experimental data, and the approach involves interpreting results in the context of clinical or biological plausibility. If prior probabilities are not well known, then Bayesian analysis (using a noninformative prior) mathematically defaults to a result similar to maximum likelihood analysis of frequentist statistical models. 13 If the sample size is large and data are normally distributed, then Bayesian estimates are similar to those generated by traditional maximum likelihood estimates. 13 Whether Bayesian analysis is used or not, study data must be rigorously collected and reviewed.
Just as one surgical procedure does not fit all patients, one statistical approach is not appropriate for all studies. Null hypothesis testing is a broadly accepted technique that is most acceptable when the true meaning of the standard P value is delineated and its limitations understood. 2 The Bayesian approach is well known in the context of diagnostic testing and is often the expected method of assessment in related studies. 8, 9 When results seem more extreme than anticipated given prior knowledge, Bayesian analysis is an appropriate way of obtaining estimates of effect, credible intervals, and tests of hypotheses beyond the null. 7 While the future may bring more journals banning P values from hypothesis significance testing 14 or a revolution toward confidence interval estimation and Bayesian methods, change is often slow. In today's publishing environs, it is important to understand the advantages and disadvantages of these 2 approaches to conduct the most appropriate analysis.
